Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Clinitech Laboratory IPO
Price Band
₹
Issue Size
₹5.78 Cr
Lot Size
1,200 shares
Min Investment
₹115,200
GMP
+₹65.0 (67.71%)
Issue Price
₹96.0
Subject to Sauda
₹59300
Paid only if allotted
Clinitech Laboratory IPO AI Summary
- Clinitech Laboratory IPO is listed on BSE SME in the Healthcare Service Provider sector.
- Subscription window: 25 Jul–29 Jul 2024, listing on 01 Aug 2024.
- Current GMP is +₹65.0 (67.71%) — unofficial and can change daily.
Clinitech Laboratory Limited is a healthcare service provider with a strong focus on diagnostic testing. The company is poised for growth with plans to expand its diagnostic centers, although it has recently seen a decline in profit. Investors should consider the company's market position and the associated risks before participating in the IPO.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Clinitech Laboratory IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 29 Jul 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Clinitech Laboratory IPO Grey Market Premium (GMP) Today
GMP
+₹65.0
GMP %
+67.71%
Est. Listing
₹161.0
Updated: 25 Jul 2026 14:05
About the Company
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services. The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests. Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment. The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012. As of May 31, 2024, the company employed 85 people in various departments.
Company Financials (₹ Cr)
As of 2024-03-31
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 5.61 | 6.03 | 3.69 | 2.73 |
| Total Income | 6.44 | 6.36 | 6.46 | 4.60 |
| Profit After Tax | 0.37 | 0.61 | 0.51 | 0.40 |
| NET Worth | 3.55 | 2.38 | 1.85 | 1.39 |
| Reserves and Surplus | 1.87 | 0.88 | 0.35 | 0.72 |
| Total Borrowing | 0.86 | 1.03 | 0.89 | 0.54 |
Key Ratios
EPS
₹2.21
NAV
₹21.12
RoNW
10.46%
P/B Value
4.55
P/E Ratio
43.45
Market Cap
₹21.91 Cr
PAT Margin
5.76%
Debt/Equity
0.24
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic |
|---|---|---|---|---|
| Krsnaa Diagnostics Limited | 250.79 | 7.02% | 38.42 | 17.9 |
| Thyrocare Technologies Ltd | 99.65 | 13.17% | 47.56 | 13.42 |
| Dr Lalpath Labs | 225.85 | 19.19% | 67.92 | 43.05 |
| Clinitech Laboratory Limited This IPO | 21.12 | 10.46% | 43.45 | 2.37 |
Promoters
Jagdish Umakant Nayak, Jyoti Jagdish Nayak and Ashutosh Jagdish Nayak
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Expansion of Diagnostic Centres 4.99 2 General Corporate Purposes 0.41
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total Income was ₹6.36 Cr for the period ending 31 Mar 2023, slightly increasing to ₹6.44 Cr by 31 Mar 2024. This indicates a modest growth in revenue over the year.
Profit Trend
Profit After Tax was ₹0.61 Cr for the period ending 31 Mar 2023, decreasing to ₹0.37 Cr by 31 Mar 2024. This decline is notable, though it is worth mentioning that this is a 9-month figure, not a full year, so isn't directly comparable.
Valuation
Clinitech Laboratory has an implied P/E ratio of 43.45 at the issue price. This is compared to its peers, which have P/E ratios ranging from 38.42 to 67.92.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the price at which shares are expected to trade in the unofficial market before listing. A positive GMP suggests strong demand for the shares, while a negative GMP may indicate weaker interest.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's growth potential and market position.
Who May Want to Wait
Investors who are risk-averse or uncomfortable with potential fluctuations in stock prices may want to avoid IPOs, as they can be subject to significant price volatility in the early stages of trading.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor might make on the first day of trading if the stock price rises above the issue price. However, such gains are not guaranteed and can be influenced by market conditions and investor sentiment.
This evaluation is generated from Clinitech Laboratory's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Clinitech Laboratory IPO GMP today?
Clinitech Laboratory IPO GMP today is +₹65.0 (67.71%). GMP is an unofficial grey-market indicator and can change daily.
When does Clinitech Laboratory IPO open and close?
Clinitech Laboratory IPO opens on 25 July 2024 and closes on 29 July 2024.
When does Clinitech Laboratory IPO list on the stock exchange?
Clinitech Laboratory IPO listed on 01 August 2024 at ₹161.0.
What is the lot size for Clinitech Laboratory IPO?
The lot size for Clinitech Laboratory IPO is 1200 shares, requiring a minimum investment of ₹115,200.
What is the lot size for this IPO?
The lot size for Clinitech Laboratory's IPO is 1200 shares.
What is the minimum investment required?
The minimum investment required is ₹115,200.
What is the issue price of the shares?
The issue price of the shares is ₹96.00.
When is the listing date for this IPO?
The listing date for Clinitech Laboratory's IPO is August 1, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected price at which shares will trade in the grey market before they are officially listed.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
25 Jul 2024
Close
29 Jul 2024
Allotment
30 Jul 2024
Listing
01 Aug 2024
Similar IPOs in Healthcare Service Provider
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Clinitech Laboratory?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.